A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 15, 2020

Study Completion Date

May 15, 2020

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix

Trial Locations (19)

Unknown

S. P Medical College and AG of Hospitals, Bikaner

Krishna Institute of Medical Sciences, Secunderabad

Bodyline Hospitals, Ahmedabad

HCG Multi Specialty Hospital, Ahmedabad

Shalby Hospital, Ahmedabad

HealthCare Global Enterprises Limited, Bangalore

KLE's Dr. Prabhakar Kore Hospital & MRC, Belagavi

Apollo Speciality Hospital, Chennai

Rajiv Gandhi Cancer Institute and Research Centre, Delhi

Muljibhai Patel Urological Hospital, Gujrāt

CHL Hospital, Indore

SMS Medical College & Attached Hospital's, Jaipur

Tata Medical Center, Kolkata

King's George Medical University, Lucknow

Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai

Tata Memorial Hospital, Mumbai

Government Medical College and Super Specialty Hospital, Nagpur

Rml & Pgimer, New Delhi

Aman Hospital and Research Center, Vadodara

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT02726009 - A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer | Biotech Hunter | Biotech Hunter